MOSS — Moss Genomics Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$0.90m
- CA$0.87m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.011 | -0.001 | -0.108 | -0.655 | -0.73 |
Depreciation | |||||
Non-Cash Items | — | — | — | — | 0.1 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.009 | 0.001 | 0.107 | 0.049 | -0.13 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -0.001 | -0 | -0.002 | -0.568 | -0.715 |
Capital Expenditures | — | — | — | -0.051 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | — | 0.046 | 0 |
Sale of Business | |||||
Cash from Investing Activities | — | — | — | -0.005 | 0 |
Financing Cash Flow Items | — | — | — | 0.308 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.002 | 0 | 0.002 | 1.26 | 0.045 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.001 | -0 | -0 | 0.687 | -0.67 |